Journal of Ophthalmic Science· ISSN 2470-0436· Open Access Pub
Editorial Board
The people who decide what this journal publishes, the appointments they hold, and the process they apply to a manuscript.
- 13Editors
- 8Countries
- 8Available ORCID iDs
- Single-blindReview model
I
Who decides what this journal publishes
The Editor-in-Chief holds final responsibility for what the journal publishes and for the standards applied to it. The Editor-in-Chief screens submissions for scope, assigns handling editors and receives editorial appeals.
Editor-in-Chief
Federico Gonzalez-Fernandez
, united states
Retina research photoreceptor biology interphotoreceptor matrix ophthalmic pathology
Submissions are screened by the Editor-in-Chief on arrival. A manuscript outside the journal's scope, or with flaws that review could not remedy, may be returned without external review; everything else is assigned to a handling editor. Complex ethical questions and appeals are referred to the Editor-in-Chief for adjudication.
II
What the board does with a manuscript
Members do not vote on submissions and do not all see every paper. One handling editor takes each manuscript, chooses its reviewers, and recommends a decision.
- Assignment
- The Editor-in-Chief assigns each submission to a handling editor, who confirms scope fit, completeness and basic quality before external review is considered.
- Conflicts and recusal
- Editors and reviewers declare any personal, financial or institutional conflict with the authors or the research topic, and recuse themselves from any manuscript where objectivity could be compromised.
- Choosing reviewers
- The handling editor identifies three to five reviewers matched to the manuscript's subspecialty, screens them for conflicts, and avoids anyone who has recently collaborated with the authors. Reviewers are drawn from the wider specialist community, not only from this board.
- Review
- Review is single-blind. Manuscripts that proceed to external peer review are normally evaluated by at least two independent ophthalmology specialists. Timing depends on the manuscript, reviewer availability and any ethics or integrity questions.
- Methodological review
- Manuscripts with complex statistical analyses, clinical trials or epidemiological designs carry at least one reviewer with methodological or biostatistical expertise in addition to the clinical reviewers.
- Disagreement between reviewers
- Conflicting recommendations are not averaged. The handling editor evaluates each reviewer's argument, may commission a further review, and gives written justification for the recommendation.
- Confidentiality
- Editors maintain strict confidentiality of manuscript contents and of reviewer identities.
- Editorial independence
- Editorial decisions rest on scientific merit and are independent of article charges, membership and any optional service.
- Appeals
- An author who disagrees with a decision may submit a formal appeal to the Editor-in-Chief within 30 days, with justification and any additional evidence.
- Corrections and retractions
- Minor errors found after publication are addressed by an erratum or corrigendum; serious errors affecting a paper's conclusions by a correction notice with an updated version of the article; and evidence of misconduct or fabrication by retraction under COPE guidance.
| Decision | Criteria | What the author does next |
|---|---|---|
| Accept | Meets all standards; no or trivial revisions needed | Proceeds to production |
| Minor revision | Sound but requires clarification or minor improvement | A focused revision may be invited |
| Major revision | Significant issues that substantial revision could address | Further review may be required |
| Reject | Fundamental flaws in design, methods, ethics, integrity or scope that revision cannot resolve | A substantially new study may be submitted as a new manuscript |
The four decisions a handling editor may recommend, with the revision period each carries.
III
Editorial board
13 editors in 8 countries. Each entry shows the appointment stored in the public journal record. Public ORCID iDs are linked where available. ORCID absence does not imply a lack of expertise or invalidate an editorial appointment.
Editorial Board
TURKEY
Cataract Surgery, Glaucoma, Dry eye, Retina, Retinopathy of Prematurity.
ORCID 0000-0002-7952-1241
Editorial Board
Italy
Ophthalmology, Retinal Diseases, Retinal Degeneration, Eye Diseases, Macular Degeneration, OCT, Cataract Surgery, Cornea, Retinal Imaging, Phacoemulsification
ORCID 0000-0002-3993-9803
Editorial Board
Spain
Ophthalmology specialties Retina and Vitreous Cataract Glaucoma New technologies
Editorial Board
United States
Inquiry into advanced retinal imaging technologies to investigate a wide range of ocular diseases. Conducted company-sponsored trials for FDA approvals. Research related to better understanding and treatment of pathologies as age-related macular degeneration, diabetic retinopathy, glaucoma, retinal vein occlusion, degeneration and detachment among others. Imaging modalities included optical coherence tomography, fluorescein angiography, fundus photography, microperimetry and canfield camera imaging. Also have clinical and research interests in Cornea, cataract, IOL's, pterygium pathogenesis.
Editorial Board
Iran
Ophthalmology, Dermatology, Cosmetic Surgery, Surgery, Cardiovascular disease, Artificial Intelligence
ORCID 0000-0001-5774-4607
Editorial Board
UNITED KINGDOM
Healthcare/Assistive technology, participatory design, user centred design.
ORCID 0000-0001-9518-4997
Editorial Board
united states
Electrophysiology, Retina, Retinal circuitry, Synaptic transmission, Phototransduction, Ion channels, G-protein coupled receptor, Second messengers
ORCID 0009-0009-7359-3875
Editorial Board
United States
Visual Optics, Applied Optics, Corneal Diseases, Keratoconus, Macular Degeneration, Glaucoma, OCT, Anterior Eye Segment
IV
What the board covers
The areas below are those in which members have a published record. They are what the board can assess directly.
- Retina research photoreceptor biology interphotoreceptor matrix ophthalmic pathology
- Gonzalez-Fernandez
- Cataract Surgery
- Celebi · Interlandi · Ong
- Glaucoma
- Celebi · Shi
- Dry eye
- Celebi
- Retina
- Celebi · Jiang
- Retinopathy of Prematurity.
- Celebi
- Cornea
- Interlandi · Tzamalis
- Cataract
- Tzamalis
- Oculoplastics
- Tzamalis
- Cataracts
- DeBroff
- Eye Care
- DeBroff
- Ophthalmology
- DeBroff · Interlandi · Naderan
- Retinal Diseases
- Interlandi
- Retinal Degeneration
- Interlandi
- Eye Diseases
- Interlandi
- Macular Degeneration
- Interlandi · Shi
- OCT
- Interlandi · Shi
- Retinal Imaging
- Interlandi
- Phacoemulsification
- Interlandi
- Ophthalmology specialties Retina and Vitreous Cataract Glaucoma New technologies
- March de Ribot
- Inquiry into advanced retinal imaging technologies to investigate a wide range of ocular diseases. Conducted company-sponsored trials for FDA approvals. Research related to better understanding and treatment of pathologies as age-related macular degeneration
- Maram
- diabetic retinopathy
- Maram
- glaucoma
- Maram · McElnea
- retinal vein occlusion
- Maram
- degeneration and detachment among others. Imaging modalities included optical coherence tomography
- Maram
- fluorescein angiography
- Maram
- fundus photography
- Maram
- microperimetry and canfield camera imaging. Also have clinical and research interests in Cornea
- Maram
- cataract
- Maram
- IOL's
- Maram
- pterygium pathogenesis.
- Maram
- Dermatology
- Naderan
- Cosmetic Surgery
- Naderan
- Surgery
- Naderan
- Cardiovascular disease
- Naderan
- Artificial Intelligence
- Naderan
- ophthalmology
- McElnea
- Healthcare/Assistive technology
- Hakobyan
- participatory design
- Hakobyan
- user centred design.
- Hakobyan
- Biocompatibility
- Ong
- Biomaterials
- Ong
- Electrophysiology
- Jiang
- Retinal circuitry
- Jiang
- Synaptic transmission
- Jiang
- Phototransduction
- Jiang
- Ion channels
- Jiang
- G-protein coupled receptor
- Jiang
- Second messengers
- Jiang
- Visual Optics
- Shi
- Applied Optics
- Shi
- Corneal Diseases
- Shi
- Keratoconus
- Shi
- Anterior Eye Segment
- Shi
Where the board does not reach
No current member records pediatric ophthalmology or ocular oncology, and the journal has published in both. Manuscripts in those areas are reviewed by external specialists selected for the individual paper, which is the same mechanism used whenever a submission falls outside a board member's range.
V
What editors check before a paper can proceed
Editors work to COPE guidance and consult the COPE flowcharts when an ethical question arises during review.
- Documented institutional review board or ethics committee approval for research in human participants.
- Compliance with the Declaration of Helsinki.
- Registration of interventional clinical trials in an accepted public registry at or before the first participant provides consent for enrollment.
- Written informed consent, with explicit consent for publication of any clinical photograph showing periocular or facial features. A bar over the eyes is not accepted as a substitute for consent.
- Written publication consent for identifiable ophthalmic, periocular or facial images and case details, with unnecessary identifiers removed from every image type.
- The ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
- Authorship against the four ICMJE criteria; ghost and honorary authorship are prohibited.
- Declared financial relationships with pharmaceutical or device companies, consulting and speaker fees, patents and stock, funding sources and grant numbers.
- A data availability statement on every empirical manuscript.
- Originality screening with iThenticate, including self-plagiarism.
- Concerns about data integrity, image manipulation or plagiarism, referred to the Editor-in-Chief.
VI
Elsewhere in the journal
Submit to the Journal of Ophthalmic Science
Your manuscript is screened by the Editor-in-Chief and assigned to a handling editor. Manuscripts that proceed to external peer review are normally evaluated by at least two independent ophthalmology specialists.
Journal of Ophthalmic Science · ISSN 2470-0436 (online) · Crossref DOI prefix 10.14302 · Published by Open Access Pub.
Appointments and available ORCID iDs were checked against the journal record and the supporting institutional or publication sources documented for this preview.